Vivos Therapeutics, Inc.
Q2 2025 13F Holders
Symbol
VVOS
CUSIP
92859E207
Type
Equity
Class
COM NEW
Num filings
21
Total reported value, excl. options
$1.27 M
Compare 2025 Q2 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
Manager
Report Date
Value ($000)
Shares
Option Type